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Abstract Delivery is a stressful and risky event menacing
the newborn. The mother-dependent respiration has to be
replaced by autonomous pulmonary breathing immediately
after delivery. If delayed, it may lead to deﬁcient oxygen
supply compromising survival and development of the
central nervous system. Lack of oxygen availability gives
rise to depletion of NAD
? tissue stores, decrease of ATP
formation, weakening of the electron transport pump and
anaerobic metabolism and acidosis, leading necessarily to
death if oxygenation is not promptly re-established.
Re-oxygenation triggers a cascade of compensatory bio-
chemical events to restore function, which may be accom-
panied by improper homeostasis and oxidative stress.
Consequences may be incomplete recovery, or excess reac-
tions that worsen the biological outcome by disturbed
metabolism and/or imbalance produced by over-expression
of alternative metabolic pathways. Perinatal asphyxia has
been associated with severe neurological and psychiatric
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DOI 10.1007/s12640-010-9208-9sequelae with delayed clinical onset. No speciﬁc treatments
have yet been established. In the clinical setting, after
resuscitationofaninfantwithbirthasphyxia,theemphasisis
on supportive therapy. Several interventions have been
proposedtoattenuatesecondaryneuronalinjurieselicitedby
asphyxia, including hypothermia. Although promising, the
clinical efﬁcacy of hypothermia has not been fully demon-
strated. It is evident that new approaches are warranted. The
purpose of this review is to discuss the concept of sentinel
proteins as targets for neuroprotection. Several sentinel
proteins have been described to protect the integrity of the
genome (e.g. PARP-1; XRCC1; DNA ligase IIIa; DNA
polymerase b, ERCC2, DNA-dependent protein kinases).
They act by eliciting metabolic cascades leading to (i) acti-
vation of cell survival and neurotrophic pathways; (ii) early
and delayed programmed cell death, and (iii) promotion of
cell proliferation, differentiation, neuritogenesis and syna-
ptogenesis.Itisproposedthatsentinelproteinscanbeusedas
markers for characterising long-term effects of perinatal
asphyxia, and as targets for novel therapeutic development
and innovative strategies for neonatal care.
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Abbreviations
AIF Apoptosis-inducing factor
ADP Adenosine diphosphate
ADS Attention deﬁcit syndrome
AMP Adenosine monophosphate
ATP Adenosine triphosphate
BAD Bcl-2-associated death promoter
bFGF Basic ﬁbroblast growth factor
BAX Bcl-2-associated X protein
BCL-2 B-cell lymphoma-2
BCL-X Bcl-2-related gene
BCL-XL Bcl-X larger isoform
BCL-XS Bcl-X shorter isoform
BID BH3 interacting domain death agonist
BrdU 5-Bromo-20-deoxyuridine
CA Cornus Ammonis
CNS Central nervous system
Cr Creatine
CS Caesarean-delivered
Cdk Cyclin-dependent kinase
DAPK Death-associated protein kinase
DCX Doublecortin
DG Dentate gyrus
DIV Days in vitro
DNA Deoxyribonucleic acid
DNMT1 DNA (cytosine-5)-methyltransferase 1
DRP-1 Dynamin-related protein
Elk1 Ets like gene 1
ERCC2 Excision repair cross-complementing
rodent repair group 2
ERK Extracellular signal-regulated kinases
FBA Flux-balance-analysis
FGFR bFGF receptors
FLRT3 Fibronectin-leucin-rich
transmembrane protein
HDAC Histone deacetylases
HIF-1 Hypoxia induceble factor-1
L1 L1CAM cell adhesion molecule
MAP-2 Microtubule-associated protein-2
MAPK Mitogen-activated protein kinase
NAD Nicotinamide adenine dinucleotide
NADH Reduced nicotinamide adenine
dinucleotide
NF-jB Nuclear factor jB
Ngn2 Neurogenin-2
NgR Nogo receptor
nNOS Neuronal nitric oxide synthase
PARG Poly-(ADP-ribose) glycohydrolase
PARylated PARP Poly-(ADP-ribosylated) PARP
PARPs Poly(ADP-ribose) polymerases
PCAF p300/CBP-associated factor
PCr Phospho creatine
PIP2 Phosphatidylinositol-4,5-diphosphate
PKC Protein kinase C
ROS Reactive oxygen species
Sef Similar expression fgf gene
SIRT Sirtuin
SOD Superoxide dismutase
Spry Sprouty
SRY Sex determining region Y
SVZ Subventricular zone
TH Tyrosine hydroxylase
Thy-1 THY thymocyte differentiation
antigen 1
TUNEL TdT-mediated dUTP nick-end
labelling
XRCC1 X-ray Cross Complementing Factor 1
Perinatal asphyxia: a long-lasting metabolic insult
A temporal interruption of oxygen availability implies a
risky metabolic challenge whenever the insult is not lead-
ing to a fatal outcome. Interruption of oxygen availability
at birth implies a radical shift from an aerobic to a less
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123efﬁcient anaerobic metabolism, resulting in (i) a decrease
of the rate of ATP formation (Lubec et al. 2000; Seidl et al.
2000); (ii) lactate accumulation (Chen et al. 1997a); (iii)
decreased pH (Engidawork et al. 1997; Lubec et al. 2000),
and (iv) over production of reactive oxygen species (ROS)
(Kretzchmar et al. 1990; Hasegawa et al. 1993; Ikeda et al.
1999; Tan et al. 1999). ATP deﬁcit implies a weakened
electron transport pump (Numagani et al. 1997), intracel-
lular calcium accumulation (Akhter et al. 2000) and, if
prolonged, DNA fragmentation (Akhter et al. 2001).
Re-oxygenation is a requisite for survival, but it can lead
to improper homeostasis, partial recovery and sustained
over-expression of alternative metabolic pathways, pro-
longing the energy deﬁcit and/or generating oxidative
stress. Oxidative stress has been indicated as a factor
associated with inactivation of a number of enzymes;
including mitochondrial respiratory enzymes (see Gitto
et al. 2002).
Clinical relevance
Perinatal asphyxia still occurs frequently whenever deliv-
ery is prolonged, despite improvements in perinatal care
(Berger and Garnier 2000; Volpe 2001;L o w2004; Van-
nuci and Hagberg 2004). The international incidence has
been reported to be 2–6/1,000 term births (de Hann et al.
2006), reaching larger rates in developing countries (Lawn
et al. 2005). After asphyxia, infants can suffer from long-
term neurological sequelae, the severity of which depends
upon the extent of the insult. Severe asphyxia has been
linked to cerebral palsy, mental retardation and epilepsy,
while mild-severe asphyxia has been associated with
attention deﬁcits and hyperactivity in children and ado-
lescents (Man ˜eru et al. 2001, 2005). No strict correlation
has been demonstrated yet between the clinical outcome
and the severity and/or the extent of the insult, but there is a
correlation between recovery and outcome (Bracci et al.
2006; Triulzi et al. 2006; Perlman 2006). In a recent cohort
study monitoring 5,887 children for 8 years, it was shown
that resuscitated infants, asymptomatic for encephalopathy,
showed an increased risk for low IQ score (Odd et al.
2009).
In the clinical scenario, after resuscitation, the emphasis
is on supportive therapy to stabilize systemic physiological
parameters. Many concepts have been put forth to prevent
the long-term neurological consequences of the insult, or
about procedures to re-establish oxygenation without fur-
ther worsening the outcome, but, only hypothermia has
been shown to be neuroprotective both experimentally and
clinically. While several meta-analysis studies have
reported promising results (Edwards 2009; Shah 2010),
there is still a need for further research demonstrating a
long-term neuroprotective value (Azzopardi et al. 2009; see
Groenendaal and Brouwer 2009; Edwards 2009; Shah
2010). A major limitation is the rather narrow therapeutic
window, as clearly demonstrated by convincing experi-
mental studies (Engidawork et al. 2001; Roelfsema et al.
2004; Hoeger et al. 2006). Furthermore, van den Broek
et al. (2010) have recently discussed the proposed roles of
hypothermia in modifying several pharmacokinetic and
pharmacodynamic features of drugs used in neonatology.
Regional and developmental vulnerability
Amongst other brain regions, neurocircuitries of the basal
ganglia, but also of hippocampus, are particularly vulner-
able to global anoxia/ischaemia occurring at neonatal
(Pasternak et al. 1991; Pastuzko 1994; Cowan et al. 2003;
Miller et al. 2005; Barkovich 2006) and adult stages
(Pulsinelli et al. 1982; see Haddad and Jiang, 1993;
Calabresi et al. 2000; Venkatesan and Frucht, 2006). Our
previous study conﬁrmed that vulnerability, assayed with
immunochemistry (Andersson et al. 1995; Dell’Anna et al.
1997; Chen et al. 1997a, b; Morales et al. 2003, 2005;
Klawitter et al. 2005), molecular biology (Andersson
et al. 1995; Gross et al. 2000, 2005), in vivo (Dell’Anna
et al. 1995;1997; Chen et al. 1997c), in vitro (Morales et al.
2003; Klawitter et al. 2005, 2006, 2007) and/or ex vivo
(Ungethu ¨m et al. 1996; Chen et al. 1997c; Bustamante
et al. 2003) biochemistry, supporting the idea that the
regional impact of the insult is related to (i) the severity
(extent) of the insult; (ii) the metabolic imbalance during
the re-oxygenation period, and (iii) the developmental
stage of the affected region.
The immature brain is particularly vulnerable to meta-
bolic insults, including oxidative stress. Along a series of
seminal studies, Ralf Dringen in Tuebingen, Germany
(Dringen 2000; Dringen et al. 2005), demonstrated that,
during development, antioxidant mechanisms are not sufﬁ-
ciently expressed and do not respond to oxidative stress in a
comparable manner to the adult brain (see also McQuillen
andFerreiro2004).Thisisattributedpartlytohighfattyacid
content oftheyoungbrain,itshighoxygenconsumptionand
oxidative phosphorylation (Dringen et al. 2005).
In the central nervous system (CNS) of mammals,
including man, neuronal and glial growth and differentia-
tion are predominantly postnatal events (Altman 1967).
Neuronal migratory pathways have different developmen-
tal time-courses, e.g. dopamine-containing neuronal path-
ways have an earlier and faster development than
noradrenaline- and 5-hydroxytryptamine pathways (Loizou
1972). Similarly, mesencephalic and telencephalic struc-
tures are differently developed at birth and the functional
development of striatal neurocircuitries depends upon
Neurotox Res (2011) 19:603–627 605
123mesencephalic and neocortical inputs. The neocortex lar-
gely matures at postnatal stages. Indeed, in the rat, neo-
cortical pyramidal projections enter physiologically viable
states only 1 week after birth (Li and Martin 2000; Meng
and Martin 2003; Meng et al. 2004). Furthermore, while
the rat at postnatal day 1 (P1) possesses the same number
of dopamine cell bodies as in adulthood, proliferation of
their terminal network is largely undeveloped (Olson and
Seiger 1972; Loizou 1972; Seiger and Olson 1973; Voorn
et al. 1988). Dopamine ﬁbres start to invade the neostria-
tum before birth (Seiger and Olson 1973), but dopamine-
containing axon terminals reach a peak at the fourth post-
natal week, and a mature targeting is only achieved after
several postnatal weeks, when patches are replaced by a
diffuse dopamine innervation pattern (Antonopoulos et al.
2002). Indeed, dopaminergic axons continue to grow at a
slow rate during adulthood (Loizou 1972; Voorn et al.
1988). There are also waves of naturally dying dopamine
neurons occurring postnatally, which increases the sus-
ceptibility of surviving neurons to energy failure (Oo and
Burke 1997; Antonopoulos et al. 2002).
Early and delayed cell death
Cell death can occur by different mechanisms, i.e. necrosis,
following severe fulminate insults, or apoptosis, whenever
the organism has time to organize a programmed death.
Necrosis can be observed within minutes, while apoptosis
takes more time to develop (Bonfocco et al. 1995). No
gross morphology indicating necrotic cell death has been
found in rat pups surviving short- or long-periods of peri-
natal asphyxia, when the main experimental parameter is
anoxia (Dell’Anna et al. 1997). Nevertheless, several
neurochemical and immunocytochemical studies have
shown speciﬁc neuronal changes at short (Dell’Anna et al.
1995; Chen et al. 1997a), and extended time intervals after
the insult (Andersson et al. 1995; Dell’Anna et al. 1997,
Chen et al. 1997a, b, c), which may explain behavioural
and cognitive deﬁcits occurring with a delayed onset (Chen
et al. 1995; Simola et al. 2008; Morales et al. 2010).
Dell’Anna et al. (1997) studied changes in nuclear
chromatin fragmentation at 80 min to 8 days after perinatal
asphyxia, observing a progressive and delayed increase in
nuclear fragmentation that was dependent upon the dura-
tion of the perinatal insult. The most evident effects were
seen in frontal cortex, neostriatum and cerebellum at P8.
These observations have been replicated by several labo-
ratories, suggesting an apoptotic mechanism (Nakajima
et al. 2000; Northington et al. 2001; Morales et al. 2008).
This can be a rather simpliﬁed view, because cell death
phenotypes can be heterogeneous after neonatal insults.
Indeed, apoptotic cells can undergo secondary necrosis,
when the amount of apoptosis overwhelms the ability of
the tissue to remove the cellular debris by phagocytosis
(Bonfocco et al. 1995; Portera-Cailliau et al. 1997a, b).
While phagocytosis is probably accomplished by microg-
lia, there is an autophagic mechanism in each cell for
sequestration of proteins and damaged organelles into
vesicles named autophagosomes, which are fused with
lysosomes for degrading their contents (see Shintani and
Klionsky 2004). In neurons, autophagy can be linked to
apoptosis, but it can represent an independent programmed
cell death, also increased by neonatal hypoxia/ischaemia
(Ginet et al. 2009). Several protein families involved in
apoptosis are activated by neonatal hypoxia–ischaemia
including BCL-2 and BCL-XL, which promote survival
(Howard et al. 2002), and BAX, BID, BCL-XS and BAD,
which promote cell death (Yang et al. 1995; see Morales
et al. 2008). Moreover, members of the death-associated
protein kinase family, DAPK and DRP-1 have been asso-
ciated to autophagy by a caspase-independent mechanism
(see Shintani and Klionsky 2004).
Postnatal neurogenesis
Postnatal neurogenesis occurs in dentate gyrus (DG) of the
hippocampus and subventricular zone (SVZ) of mammals,
including humans (Alvarez-Buylla and Lim 2004; Ming
and Song 2005; Zhao et al. 2008), probably for neuronal
replacement. Indeed, increased neurogenesis has been
observed in the SVZ following anoxic/ischaemic insults,
producing neuroblasts that can migrate, differentiate and
develop to functionally competent neurons, to be integrated
into injured areas (Collin et al. 2005,B e ´dard et al. 2006).
Neuroblasts from the subgranular zone of the DG migrate
to the inner granular cell layer, their axons project to the
CA3, and their dendrites extend into the molecular layer
(Hastings and Gould 1999). Several reports have shown
that neurogenesis in the DG is increased following anoxic/
ischaemic insults (Scheepens et al. 2003; Bartley et al.
2005; Morales et al. 2005, 2008).
Basic ﬁbroblast growth factor (bFGF) has been identi-
ﬁed as a factor promoting cell survival and neurogenesis
(Takami et al. 1992; Cheng et al. 2002, Ganat et al. 2002),
through activation of the MAPK/extracellular signal-regu-
lated kinases (ERK) pathway (Mudo ` et al. 2009; Morales
et al. 2008). Along these lines, the expression of bFGF has
been observed to be upregulated in DG and SVZ following
perinatal asphyxia (Plane et al. 2004; Morales et al. 2008;
Suh et al. 2009), possibly to prevent cell death (Han and
Holtzman 2000). Several proteins have been identiﬁed as
modulators of the transduction cascade elicited by bFGF
receptors (FGFR) during embryogenesis, including Spry,
Sef and FLRT3 (Tsang and Dawid 2004). Spry and Sef
606 Neurotox Res (2011) 19:603–627
123provide inhibitory regulation, while FRLT3 stimulates the
activation of FGFR and ERK (Tsuji et al. 2004). Interest-
ingly, ERK2 phosphorylation is modulated by PARP-1,
promoting the expression of c-fos (Cohen-Armon et al.
2007), directly or via Elk1. bFGF requires proteoglycans to
achieve full activation of FGFR, involving the action of
phosphatases and the formation of a ternary complex,
comprised by the proteoglycan syndecan-4, phosphatidyl-
inositol 4,5 bisphosphate (PIP2) and protein kinase Ca
(PKCa) (Horowitz et al. 2002). Whether these pathways
occur postnatally to regulate the cellular response to injury
is not yet known.
Proteins involved in cell migration, neurite outgrowth
and synaptic targeting
Several cell adhesion molecules of the immunoglobulin
superfamily are involved in cell migration, neurite out-
growth and synaptic targeting. L1 and b1 integrins con-
verge with growth factor signalling, activating the MAPK/
ERK pathways. L1 also interacts with Ephrin/EphB pro-
teins, promoting axon branching (see Schmid and Maness
2008). Additionally, L1 promotes homophilic interactions
with L1 itself, as well as a number of different heterophilic
interactions with molecules including avb3 integrin, axo-
nin-1 and contactin/F3 to promote neurite outgrowth (Zhao
et al. 1998; De Angelis et al. 1999; Ruppert et al. 1995;
Montgomery et al. 1996). More than 100 mutations in L1
have been found in humans, associated with severe neu-
rological dysfunctions, including agenesis of the cortico-
spinal tract and the corpus callosum, spastic paraplegia and
mental retardation (Kenwrick et al. 2000), supporting its
role in CNS development. L1 localises in the same com-
partment as microtubule-associated protein-2 (MAP-2), a
somatodendritic marker (Demyanenko et al. 1999). Fur-
thermore, it has been reported that the hippocampus of L1
mutant mice is smaller than in normal animals, suggesting
that L1 is relevant for the regulation of hippocampal
development (Demyanenko et al. 1999). L1 also plays a
function in the organization of dopaminergic neurons in
mesencephalon and diencephalon, modulating extension of
growth cones to different synaptic targets (Demyanenko
et al. 2001).
Neuritogenesis and synaptogenesis require speciﬁcity,
which has to be preserved when building functional neu-
rocircuitries. Hence, the relevance of inhibitory proteins,
such as Thy-1 and Nogo receptor (NgR), counteracting the
effect of stimulatory proteins, such as L1, is highly rele-
vant. Thy-1 is abundantly expressed on the surface of most
neurons in the CNS, but its expression is regulated during
development, appearing in the early postnatal period
(Morris et al. 1985). Thy-1 has been considered to be a cell
adhesion molecule belonging to the immunoglobulin
superfamily. However, many studies now support the idea
that Thy-1 plays the role of an inhibitory protein modu-
lating axonal growth (Morris et al. 1992; Chen et al. 2005).
Indeed, it has been suggested that Thy-1 limits axonal
growth in order to stabilize neuronal connections during
postnatal development (Morris et al. 1992; Barlow and
Huntley 2000).
The inhibitory function of Thy-1 in neurons occurs by
binding to expressed by astrocytes (Tiveron et al. 1992;
Dreyer et al. 1995). Our previous studies indicate that upon
binding to both avb3 integrin and syndecan-4, Thy-1
triggers tyrosine phosphorylation of focal adhesion pro-
teins, increases RhoA activity and promotes the attachment
and spreading of astrocytes (Leyton et al. 2001; Avalos
et al. 2002, 2004, 2009; Hermosilla et al. 2008). It has not
yet been reported whether binding of Thy-1 to avb3 pre-
vents neurite extension. Thus, the regulation of neurito-
genesis and synaptogenesis by bFGF, L1 and Thy-1 is
exciting in that they interact with syndecan-4 and/or avb3
integrin, but triggering opposite effects. The ﬁne tuning of
these events likely is controlled by the temporal and spatial
expression of these proteins. Indeed, (i) avb3 integrin is not
normally expressed in the adult brain, but it is expressed
after stroke or other brain insults (Ellison et al. 1998); (ii)
syndecan-4, although ubiquitously expressed in small
amounts, up-regulates its mRNA and core protein levels at
day 4 post-injury (Iseki et al. 2002).
NgR is also a neuronal protein inhibiting neurite out-
growth. The expression of NgR and its ligand Nogo-A are
up-regulated in rats subjected to hypoxia–ischaemia at P7,
indicating their relevance to metabolic insults affecting
neonates (Wang et al. 2006). Nogo-A is expressed in
myelin-forming oligodendrocytes, and inhibition of either
the receptor or the ligand leads to axonal sprouting and
functional recovery of damaged neurons (Wiessner et al.
2003; Li et al. 2005), supporting the idea of NgR as an
inhibitory protein regulating neuronal processes. Astro-
cyte avb3 integrin and other oligodendrocytes, but also
neuronal proteins, provide targets for modulating brain
regeneration capacity, and open therapeutic avenues for
individuals affected by hypoxia. Indeed, perinatal
asphyxia has been associated with an increased sprouting
in stratum oriens of dorsal hippocampus, promoting the
formation of new recurrent excitatory branches from the
mossy ﬁbre projection to the CA3 region (Morales et al.
2010).
Sentinel proteins
Suppression and/or over-activation of gene expression
occurs immediately or during the re-oxygenation period
Neurotox Res (2011) 19:603–627 607
123following perinatal asphyxia (Labudova et al. 1999; Seidl
et al. 2000; Mosgoeller et al. 2000; Lubec et al. 2002).
When the DNA integrity is compromised, a number of
sentinel proteins are activated, including (i) poly(ADP-
ribose) polymerases (PARPs) (Ame ´ et al. 2004); (ii) X-ray
Cross-Complementing Factor 1 (XRCC1) (Green et al.
1992); (iii) DNA ligase IIIa (Leppard et al. 2003); (iv)
DNA polymerase b (Wilson 1998; Mishra et al. 2003); (v)
Excision Repair Cross-Complementing Rodent Repair
Group 2 (ERCC2) (Sung et al. 1993; Chiappe-Gutierrez
et al. 1998; Lubec et al. 2002) and (vi) DNA-dependent
protein kinases (de Murcia and Menissier de Murcia 1994).
PARP proteins act as ADP-ribose transferases, trans-
ferring ADP-riboses from nicotinamide adenine dinucleo-
tide (NAD
?) to glutamic and aspartic residues of the
PARPs and their substrates. PARPs also catalyse the
polymerization of ADP-riboses via glycosidic bonds, cre-
ating long and branched ADP-ribose polymers. PARP-1 is
the most abundant and conserved member of a large
superfamily comprising at least 18 PARP proteins, encoded
by different genes, but displaying a conserved catalytic
domain (see Ame ´ et al. 2004). PARP-1 is involved in DNA
repair, but it might also promote cell death (De Murcia and
Menissier de Murcia 1994; see recently Kauppinen and
Swanson 2007; Cohen-Armon 2008). When DNA damage
is mild, PARP-1 is involved in the maintenance of chro-
matin integrity, by signalling cell-cycle arrest and/or by
activating DNA repairing molecular cascades. PARP-1 is
also involved in the regulation of cell proliferation and
differentiation, and modulates the transcription of several
inﬂammatory signals, including Nuclear Factor (NF)-jB
(Hassa and Hottinger 1999). Excessive PARP-1 activation
leads to NAD
? exhaustion and energy crisis (Berger 1985),
and to caspase-independent apoptosis, via translocation of
the mitochondrial pro-apoptotic protein Apoptosis-Induc-
ing Factor (AIF) to the nucleus, initiating nuclear con-
densation (Jiang et al. 1996; Yu et al. 2002; Hong et al.
2004), and a cascade of events exacerbating the biological
outcome. Thus, PARP-1 has been shown to be involved in
the long-term effects produced by perinatal asphyxia
(Martin et al. 2005). However, other sentinel proteins are
probably involved as well, modulating epigenetic pro-
cesses, such as methylation (Caiafa et al. 2009), acetylation
(Rajamohan et al. 2009) and phosphorylation (Cohen-Ar-
mon et al. 2007), rendering access to information that is
present in the DNA without inducing genetic mutation (see
Caiafa et al. 2009).
Sentinel proteins cross-talk
PARP-1, XRCC1, DNA ligase IIIa and DNA polymerase-b
are molecular partners, working in tandem to repair
single-strand breaks. DNA ligase IIIa has an N-terminal
zinc ﬁnger interacting with the DNA binding domain of
PARP-1 and the DNA strand breaks. DNA Ligase IIIa also
interacts with XRCC1, resulting in the formation of a DNA
Ligase IIIa-XRCC1 complex (see Ellenberger and
Tomkinson 2008). DNA polymerase-b is functionally
coupled to PARP-1, DNA Ligase IIIa and XRCC1,
although the molecular basis for that coupling has not yet
been clariﬁed. However, DNA polymerase-b and XRCC1
bind to single-strand breaks, contributing to the overall
stability of the repair complex, promoting polymerase
catalysis and ﬁdelity (Sawaya et al. 1997). Both PARP-1
and DNA polymerase-b are increased by hypoxia induced
in newborn piglets (Mishra et al. 2003). XRCC1 expression
is also increased by perinatal asphyxia (Chiappe-Gutierrez
et al. 1998). Indeed, using an ischaemic preconditioning
model, Li et al. (2007) demonstrated a ﬁve-fold increase of
XRCC1 levels 30 min after ischaemia, reaching a maximal
expression after 4 h. DNA polymerase-b and DNA ligase
IIIa levels were also increased, and co-expressed in neu-
ronal, but not in glial cells. Interestingly, however, only
DNA ligase IIIa levels were increased in glial cells, sug-
gesting cell-type speciﬁcity (Li et al. 2007). PARP-1 can be
phosphorylated by ERK, probably via the isoform 2
(ERK2), as a requirement for maximal PARP-1 activation
after DNA damage (Kauppinen et al. 2006). It has also been
suggested that PARP-1 can be phosphorylated by PKC, but
leading to down-regulation (Tanaka et al. 1987; Bauer et al.
1992). Cohen-Armon et al. (2007) have reported evidence
for PARP-1 activation by phosphorylated ERK2, in the
absence of DNA damage, via the signalling cascade of the
transcription factor Elk1, increasing the expression of the
immediate early gene c-fos, stimulating cell growth and
differentiation. It will be important to further study how
these sentinel proteins are expressed in in vitro and in vivo
models, and to develop therapeutic targets for inhibiting the
metabolic cascade elicited by perinatal asphyxia. Cell-type
speciﬁcity and regional distribution of sentinel proteins may
constitute regulatory mechanisms by which the long-term
effects of metabolic insults occurring at birth become het-
erogeneous, targeting some, but leaving other brain regions
apparently untouched.
PARP-1 as a target for neuroprotection
PARP-1 inhibition is emerging as a target for neuropro-
tection following hypoxia/ischaemia. The strongest evi-
dence for this hypothesis comes from studies showing that
ischaemic injuries are markedly decreased in PARP(-/-)
mice (Eliasson et al. 1997; Harberg et al. 2004). It supports
previous ﬁndings that PARP inhibitors, with increasing
degrees of potency, decrease brain damage and improve the
608 Neurotox Res (2011) 19:603–627
123neurological outcome of perinatal brain injury (Zhang et al.
1995; Ducrocq et al. 2000; Sakakibara et al. 2000; see
Virag and Szabo 2002).
The idea that PARP-1 activation is beneﬁcial has also
been explored, depending upon the actual levels of cellular
NAD
?. While PARP inhibitors offer remarkable protection
under conditions of NAD
? and ATP depletion, inhibition
of PARP-1 in the presence of NAD
? sensitises cells to
DNA damage, and subsequent increase of cell death
(Nagayama et al. 2000). Furthermore, it has been reported
that inhibition of PARP-1 can induce apoptosis in rapidly
dividing cells (Saldeen and Welsh 1998), possibly by
blocking the access of replication or repair enzymes to
DNA. G2 cell-cycle arrest may be promoted followed by
p53-independent apoptosis (Saldeen et al. 2003), and
resultant inhibition of cell proliferation.
Indeed, PARP-1 acts as both a cell survival and cell
death inducing factor by regulation of DNA repair,
chromatin remodelling and regulation of transcription.
PARP-1 overactivation following (hypoxic) stress condi-
tions may occur by p300/CBP-associated factor (PCAF)
mediated acetylation, resulting in caspase-independent
translocation of AIF from mitochondria to the nucleus and
subsequent cell death by ‘chromatinolysis’. PARP-1
activation is essential for AIF truncation and release from
mitochondria (Kolthur-Seetharam et al. 2006). Apart from
those molecular interactions, PARP-1 catalyses most
poly-ADP-ribosylations of proteins in vivo. PARP-1
interacts with proteins of the sirtuin (SIRT) family, his-
tone deacetylases (HDAC) type III, promoting cell sur-
vival (Ame ´ et al. 2004). Interestingly, PARP-1
deacetylation by SIRT results in its inactivation. Appar-
ently, the well-adjusted equilibrium between SIRT and
PARP-1 is maintained by their strict dependency from
and competition for NAD
?. Increased demand for NAD
?
by PARP-1 inhibits SIRT and vice versa (Rajamohan
et al. 2009). PARP-1 activity is also under control of, and
controls in a reciprocal manner the activity of H1-histone,
which results in exclusion of H1 from a subset of PARP-
regulated promoters and subsequent regulation of chro-
matin structure.
PARP-1 itself can be poly-ADP-ribosylated (PARylated
PARP), which is reversed by poly-ADP-ribose glycohy-
drolase (PARG). There is a link between poly-ADP-ribo-
sylation and DNA methylation, implying DNA silencing.
Indeed, it has been shown that PARG overexpression, or
reduction of PARylated PARP, results in methylation of
CpG islands in the DNA (cytosine-5-)-methyltransferase 1
(DNMT1) promoter (Zampieri et al. 2009). The ensuing
gene silencing leads to widespread, passive DNA
hypomethylation, which results in gene expression. Con-
versely, when PARylated PARP occupies the DNMT1
promoter, it protects its unmethylated state and DNMT
transcription. Additionally, other transcription factors, such
as p300, sex determining region Y (SRY), or E2F transcript
factor, are associated with PARP-1 and the DNMT1 pro-
moter (Rajamohan et al. 2009). In summary, PARP and
SIRT are at the core of epigenetic actions encompassing
DNA and histone modiﬁcations.
An experimental model of perinatal asphyxia
While the short- and long-term clinical outcome of peri-
natal asphyxia is well established, pre-clinical research is
still at an exploratory phase, mainly because of a lack of
consensus on a reliable and predictable experimental
model. A model for investigating the issue was proposed at
the Karolinska Institutet, Stockholm, Sweden, at the
beginning of the 1990s (Bjelke et al. 1991; Andersson et al.
1992; Herrera-Marschitz et al. 1993). Despite the fact that
the model is now run by several laboratories around the
world, its acceptance has not been easy, because the model
works with on term pups and not with neonates at P7. The
main argument for criticizing the model has been that
the brain of neonate rats is premature when compared to
the neonatal human brain, a statement mainly referring to
the neocortex (see Romijn et al. 1991), but also to the
pattern of oligodendrocyte lineage progression required for
cerebral myelination (Craig et al. 2003). The degree of
maturity depends upon the tissue and functions selected for
the comparisons, and vulnerability to injury may be related
to both the timing and the location of the insult (Craig et al.
2003, see also de Louw et al. 2002). Indeed, it has been
reportedthatsusceptibilitytohypoxia/ischaemiainducedby
common carotid artery ligation and hypoxemia is greater
when performed atP7rather than atearlier postnatalperiods
(Towﬁghi et al. 1997). We have chosen a rather pragmatic
approach, inducing asphyxia at the time when rats are
delivered. Several features support the usefulness of the
present model: (i) it mimics well some relevant aspects of
human delivery; (ii) it is largely non-invasive; (iii) it allows
studying short- and long-term consequences of the insult in
the same preparation, and (iv) it is highly reproducible
among laboratories. Lubec et al. in Vienna (Austria) (Lubec
et al. 1997a, b; Seidl et al. 2000) have stressed the issue that
the model is suitable for studying the early phase of peri-
natal asphyxia, as observed in the clinical setup, but per-
formed at term, during delivery. The same authors
acknowledge the fact that the model implies oxygen inter-
ruption, but not any additional lesion, including vessel
occlusion. Moreover, it is followed by hypoxemia, acidosis
and hypercapnia, mandatory criteria for a clinically relevant
model of perinatal asphyxia (Seidl et al. 2000).
The model starts by an evaluation of the oestral cycle
of young female Wistar rats (*2 months of age), in order
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123to plan for a programmed mating. A vaginal frotis is
taken for evaluating the cycle, identifying pro-oestrus,
oestrus, meta-oestrus or di-oestrous, as shown in Fig. 1.
The female is exposed to a male at the time of the pro-
oestrous for one night and thereafter the presence of a
vaginal clot is evaluated. Thus, the time of delivery is
calculated, supported by ethological and clinical obser-
vations, to predict the exact time of delivery (22 days
after a vaginal clot has been recorded). At the time of
delivery, a ﬁrst spontaneous delivery can be observed
before the dams are anaesthetized, neck dislocated and
subjected to a caesarean section and hysterectomy. The
uterine horns containing the foetuses are immediately
immersed into a water bath at 37C for various periods of
time (0–22 min). Following asphyxia, the pups are
removed from the uterine horns and resuscitated by
cleaning the faces of the animals from ﬂuid and amniotic
tissue, freeing the mouth and the nose (Fig. 2). Further
additional efforts and care are taken to induce pulmonary
breathing by touching the surface of the nose and mouth,
as well as pressing the thorax. Pups exposed to caesarean
delivery only (CS, 0 asphyxia), or to mild asphyxia
(2–10 min) are rapidly resuscitated, without requiring
anything else but removing ﬂuid and amniotic tissue from
the head. Pups exposed to zero or mild asphyxia start
breathing with a gluttonous gasp, which is rapidly
replaced by regular and synchronized breathing. For pups
exposed to longer periods of asphyxia (19–21 min),
resuscitation implies expert and skilful handling, and it
takes a long time (4–6 min) for a ﬁrst gasping, and even
longer time for establishing a more or less regular
breathing, always supported by gasping (Fig. 2). After
80 min of care taking, the pups are given to surrogate
dams for nursing, pending further experiments. An Apgar
scale is applied during the recovery period, similar to that
observed in neonatal units.
Fig. 1 Evaluation of the oestral cycle in vaginal frotises from young
female Wistar rats. A vaginal frotis is taken for evaluating the cycle,
identifying pro-oestrus, oestrus, meta-oestrus or di-oestrous. In a,
cells are in pro-oestrus: many globular, no differentiated epithelial
cells are seen, showing an apparent nucleus (thin arrow). Some
differentiated ﬂat cells, without any apparent nucleus, are also
observed (wide arrow). In b, cells are in oestrus: many differentiated
epithelial cells are seen (arrows). In c, cells are in meta-oestrus: many
degrading epithelial cells are seen (arrows) as well as leukocytes
(head arrow). In d, cells are in di-oestrus: leukocytes are the
predominant type of cells (from Klawitter 2006). Identifying a
successful mating will lead to an accurate estimation of delivery, as
well as to a decrease in the number of uncontrolled delivery impeding
the performance of the experiment. This is not a trivial outcome,
because it will safe experimental animals with the consequent
bioethical implications
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Table 1 shows the main parameters evaluated by an Apgar
scale, including weight, sex, colour of the skin, respiratory
frequency and presence of gasping, vocalization, muscular
rigidity and spontaneous movements (Dell’Anna et al.
1997; Morales et al. 2010). The Apgar evaluation is a
critical parameter for this experimental model, because it
assesses whether the pups are subjected to mild or to severe
asphyxia, which is directly determined by the percentage of
survival and recovery (Herrera-Marschitz et al. 1993,
1994). Survival is a straightforward parameter. 100% sur-
vival is observed whenever foetuses-containing uterine
horns are immersed for up to 15 min in a water bath at
37C. Thereafter, the rate of survival drops rapidly, until no
survival is observed following 22 min of asphyxia (Fig. 3).
The temperature of the water bath is a critical parameter to
be tightly controlled, because each degree below 37Ci s
associated with longer survival (Herrera-Marschitz et al.
1993, 1994; Engidawork et al. 2001). The recovery period
can also add or prolong a hypoxic/ischaemic condition, as
the surviving pups may show a decreased breathing rate,
decreased cardiovascular function and low peripheral and/
or central blood perfusion (Table 1). The Apgar evaluation
also provides information about the condition shown by the
caesarean-delivered control pups, which has to be similar
to that shown by vaginally delivered pups. Thus, the Apgar
evaluation is a requirement when using the present model
of perinatal asphyxia, because it permits to compare results
obtained by different laboratories and/or different treat-
ments. The quality of the handling of the pups and the
experience of the surrogate dam are important factors for
the acceptance and nursing of both asphyxia-exposed and
control pups.
Short-term effects produced by perinatal asphyxia
Apart from the effects produced by perinatal asphyxia on
the survival rate, the model has been shown to be useful for
describing some early molecular, metabolic and physio-
logical effects observed minutes after recovering from a
caesarean delivery, without any asphyxia, or from mild or
severe insults. Behavioural scales are normally applied
40–80 min after delivery to avoid competing with the
resuscitating and nursing manoeuvres. Tissue sampling can
be started soon after delivery. For measures of molecular
markers, tissue samples are collected immediately after
delivery, the time when the pups are removed from the
uterine horns (0 min, with or without previous immersion
into a water bath).
For measuring energy metabolism, tissue samples were
taken from peripheral organs (heart and kidneys) and brain,
removed from asphyxia-exposed and control animals
10 min after delivery and stored at -80C until analysis
(Lubec et al. 1997a, b; Seidl et al. 2000; Engidawork et al.
2001). Tissue samples were assayed for (i) energy-rich
phosphates (including ATP, ADP, AMP, Cr and PCr); (ii)
PKC and cyclin dependent kinases (Cdk); (iii) antioxidant
Fig. 2 The Karolinska Institutet experimental model of perinatal
asphyxia. The experiment starts by an evaluation of the oestral cycle
of young female Wistar rats (*2 months of age), in order to plan for
a programmed mating. The female is exposed to a male at the time of
the pro-oestrous for one night and thereafter the presence of a vaginal
clot is evaluated. Pregnancy is continuously monitored until delivery
of a ﬁrst pup is observed (representing a vaginally delivered control),
or when the maturity of the foetuses is assessed by clinical abdominal
palpation, indicating that the dam is ready for delivery (*22 days
after the identiﬁcation of a vaginal clot). The animal is anaesthetised,
killed by neck dislocation and subjected to a caesarean section and
hysterectomy. The uterine horns are then immersed into a temper-
ature-controlled water bath (37C) for various periods of time. One or
two pups are immediately delivered after hysterectomy, representing
a caesarean-delivered control. After asphyxia, the pups are removed
from the uterine horns and resuscitated by cleaning the faces of the
animals from ﬂuid and amniotic tissue, freeing the mouth and the
nose, and stimulated to pulmonary breathing. Pulmonary breathing is
further monitored and the surviving pups are evaluated by an Apgar
scale 40–60 min after delivery. Thereafter the pups are given to
surrogate dams for nursing (delivering immediately before the
hysterectomised dam), pending further experiments (see Dell’Anna
et al. 1997; Klawitter et al. 2007)
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123enzymes (SOD, catalase and glutathione peroxidase); (iv)
peroxidation products; (v) lactate, and (vi) pH.
Among the monitored energy-rich phosphates, ATP
levels showed the most evident changes, following or
anticipating the ﬁnal outcome of perinatal asphyxia. In
Fig. 3, the rate of survival is plotted together with the
changes (in percentage) of ATP levels measured 10 min
after delivery in brain, heart and kidneys. It can be seen
that the kidneys were the ﬁrst organs reacting to oxygen
interruption. ATP levels in kidneys were decreased by
[90% after 5 min of perinatal asphyxia, while ATP levels
in heart and brain were only decreased by *20% com-
pared with levels observed after no asphyxia. Only after
15 min of asphyxia, ATP levels in heart and brain started
to decrease, by approximately 70% compared with control
levels, together with a simultaneous drop in the survival
rate. After longer periods of asphyxia, ATP levels were
decreased by[90% in the brain, but only by approximately
80% in the heart after 20 min of asphyxia, when the sur-
vival rate dropped by[70%. These changes in ATP levels
nicely agree with the well-established idea of privileged
organs regarding energy availability. The kidneys are
bypassed in favour of heart and brain, but then the brain is
given up in favour of the heart that has to keep working if
Table 1 An Apgar scale for rodents
Parameters Spontaneous delivered pups
(n = 51; m = 38)
Caesarean-delivered pups
(0 min asphyxia) (n = 760; m = 176)
20 min asphyxia
(n = 923; m = 177)
Body weight (g) 6.17 ± 0.14 5.49 ± 0.08 5.52 ± 0.11
Sex (% of males) 49.2 ± 6.2 49.2 ± 5.8 41.2 ± 3
Rate of survival (%) 98.48 ± 1.52 99.52 ± 0.24 64 ± 3
Respiratory frequency (events x min
-1)6 9 ± 26 7 ± 11 8 ± 1
Presence of gasping (yes; %) 0 ± 0 0.43 ± 0.32 78 ± 8
Skin colour
Pink 97.37 ± 2.63% 96.76 ± 1.21% 1.04 ± 0.62%
Pink-blue 2.63 ± 2.63% 3.1 ± 1.18% 62.03 ± 3.51%
Blue-pink 0 ± 0% 0.14 ± 0.14% 36.17 ± 3.46%
Blue 0 ± 0% 0 ± 0% 0.75 ± 0.58%
Presence of vocalizations (yes, %) 100 ± 0% 99.71 ± 0.29% 0 ± 0%
Spontaneous movements
No movements, akinesia, rigidity (0) (%) 0 ± 00 ± 09 9 ± 1
Single movements of front legs, or head alone
(1) (%)
0 ± 00 ± 01 ± 1
Movements of two body structures (2) (%) 0 ± 0 0.14 ± 0.14 0 ± 0
Movements of all body structures (3) % 23 ± 3.23 1.45 ± 0.73 0 ± 0
Intensive movements shown by wriggling (4)
%
96.77 ± 3.23 98.27 ± 0.78 0 ± 0
Lack of reception by surrogate dams (at 24 h)
(%)
18.5 ± 6.2 21.1 ± 6.2 20.9 ± 6.2
Apgar scale for evaluating the consequences of perinatal asphyxia 40–80 min after birth. Data expressed as the mean ± SEM (n number of pups;
m number of dams)
Fig. 3 Survival and ATP levels in peripheral organs and brain.
Survival rate and ATP levels (%) found 10 min after delivery of
asphyxia-exposed and control (caesarean delivery only, zero
asphyxia) rat pups. Perinatal asphyxia was performed by immersion
of pup containing uterine horns into a water bath at 37C, removed by
a caesarean section from ready-to-deliver rats. Ten minutes after
delivery, asphyxia-exposed and control animals were decapitated for
removing brain, heart and kidneys, to be treated according to
Engidawork et al. (2001), for measuring energy-rich phosphates by
HPLC coupled to a UV detector according to Ingebretsen et al.
(1982). In control animals, ATP levels were 1.2 ± 0.2; 4.7 ± 0.1;
and 1.6 ± 0.3 lmol/g wet wt in brain (n = 7), heart (n = 16) and
kidneys (n = 16), respectively, 10 min after caesarean delivery
(n = 7). Filled circles survival rate; ﬁlled inverted triangles ATP in
brain; ﬁlled squares ATP in heart; ﬁlled triangles ATP in kidneys.
Vertical line marks the time (15 min) when survival rate starts to
drop; horizontal line marks 50%. Abscissa time (min) of immersion
into a water bath at 37C (asphyxia); ordinate survival in percentage
(%). Compared to zero asphyxia
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123any hope for survival remains. In agreement, as shown in
Fig. 4, PCr levels rapidly decreased in kidneys and brain
according to the length of asphyxia, but were largely pre-
served in the heart up to the ﬁnal outcome, probably as a
reservoir for the generation of ATP, as observed during
periods of muscular exertion. Indeed, it has been suggested
that PCr levels constitute a dynamic metabolic pool that
can facilitate transfer of high energy phosphate equivalents
from sites of ATP production at mitochondria to remotes
sites of ATP utilization, functioning as a ‘phosphocreatine
shuttle’ (Friedman and Roberts 1994). It is unlikely that
changes in PCr levels observed in the studies discussed
reﬂect a pH-dependent shift in the creatine kinase equi-
librium, as suggested by Marini and Nowak (2000), since
signiﬁcant changes in pH were already observed after
6 min of asphyxia, decreasing in parallel in peripheral and
brain tissue (Engidawork et al. 2001).
PKC and Cdk activities were measured in heart (Lubec
et al. 1997a) and brain (Lubec et al. 1997b), respectively.
As shown in Fig. 5, PKC activity was signiﬁcantly
decreased in heart and brain, already following 5 min of
perinatal asphyxia. After 15 min of asphyxia, PKC activity
was decreased by [90% in both regions. PKC changes
following ischaemia/hypoxia have been well studied (see
Puceat and Vassort 1996). PKC is involved in several
important signalling pathways, modulating ion channel
permeability and conductance (Kwank and Jongsma 1996),
as well as protein synthesis (see Pain 1986). The observed
decrease in PKC activity implies a diminished metabolism,
which may protect the animal by diminishing energy
requirement.
Cdk activity was decreased in heart, already following
mild asphyxia (5–10 min). In brain, Cdk activity paralleled
the rate of survival. Indeed, in brain, Cdk levels started to
decreased only after 19 min of perinatal asphyxia, to
become undetectable after severe asphyxia (20–21 min).
Since Cdk is involved in mitosis and proliferation (Doree
and Galas 1994), a decrease in Cdk activity implies inter-
ruption of replication and differentiation (Lubec et al.
1997b), also for diminishing energy requirements. How-
ever, as shown by Fig. 5, it is tempting to conclude that,
compared to what occurred in heart, replication and dif-
ferentiation was preserved in brain, up to an extreme
hypoxic condition. In terms of net activity (pMPi/min),
Cdk activity in brain (77.38 ± 6.78 pMPi/min; n = 8)
(Lubec et al. 1997b) was twice that found in heart
(37.43 ± 5.85 pMPi/min; n = 9) (Lubec et al. 1997a)i n
caesarean-control rats, 10 min after delivery, indicating a
higher mitogenic activity in brain than in heart at birth.
There is evidence that cell death after brain ischaemia is
associated with upregulation and activation of Cdk (Love
2003), and that inhibition of Cdk reduces neuronal loss
after brain ischaemia, in vivo or in vitro, suggesting that
activation of Cdk plays a role in post-ischaemic neuronal
death (Katchanov et al. 2001; Morris et al. 2001).
No evidence has been found for the involvement of
ROS, radical adduct and/or antioxidant enzymes when
Fig. 4 Phospho creatine (PCr) levels in brain, heart and kidneys
10 min after delivery. Survival and PCr levels were measured as
indicatedinFig. 3,andaccordingtoIngebretsen’smethod,modiﬁedby
Seidl et al. (2000) to enable concomitant determination of PCr. In
controlanimals,PCrlevelswere1.7 ± 0.3;7 ± 0.1;8.24 ± 0.2 lmol/
g wet wt in brain (n = 7), heart (n = 16) and kidneys (n = 16),
respectively, 10 min after caesarean delivery (n = 7). Filled circles
survivalrate;ﬁlledinvertedtrianglesPCrinbrain;ﬁlledsquaresPCrin
heart; ﬁlled triangles PCr in kidneys. Vertical line marks the time
(15 min) when survival rate starts to drop; horizontal line marks 50%.
pH was measured in parallel (Engidawork et al. 1997, 2001)i n
peripheral and brain tissue. pH values were 7.36 ± 0.01, and
7.30 ± 0.01, in heart and brain of control caesarean-delivered pups
(10 min after delivery); 7.25 ± 0.01 and 7.11 ± 0.01 after 5 min of
asphyxia; 7.01 ± 0.02 and 7.05 ± 0.001 after 10 min of asphyxia;
6.9 ± 0.001 and 6.79 ± 0.001 after 15 min of asphyxia, and
6.77 ± 0.01 and 6.55 ± 0.002 after 20 min of asphyxia, in heart and
brain, respectively (n = 8–10, per group). Abscissa time (min) of
immersion into a water bath at 37C (asphyxia); ordinate survival in
percentage (%). Compared to zero asphyxia
Fig. 5 PKC and Cdk in brain and heart 10 min after delivery. PKC
and Cdk activity was measured according Lubec et al. 1997a, b.I n
control animals, PKC activity was 401.63 ± 26.08, and
109.64 ± 26.65 U/g, in brain (n = 8) and heart (n = 8) 10 min after
caesarean delivery, respectively. Cdk activity was 77.38 ± 6.78, and
37.63 ± 3.93 pMPi/min, in brain (n = 8) and heart (n = 8) 10 min
after caesarean deliver, respectively. Filled circles survival rate; ﬁlled
inverted triangles PKC activity in brain; ﬁlled diamonds Cdk activity
in brain; ﬁlled squares PKC activity in heart; ﬁlled triangles Cdk
activity in heart. Vertical line marks the time (15 min) when the
survival rate starts to drop; horizontal line marks 50%. Abscissa time
(min) of immersion into a water bath at 37C (asphyxia); ordinate
survival in percentage (%). Compared to zero asphyxia
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123evaluated 10 min after delivery (Lubec et al. 1997a), sug-
gesting that reactive oxygen species may not be relevant in
this model. Nevertheless, brain glutamate and lactate levels
are signiﬁcantly increased ([2-fold) when measured
40–80 min after birth by in vivo microdialysis, both in
periphery (Engidawork et al. 1997) and brain (Chen et al.
1997a), correlating with a decrease of pH, suggesting a
delayed oxidative stress elicited by the re-oxygenation
period.
Cell death was evaluated in the frontal neocortex, 10 and
40 min after delivery, using an ELISA kit (Boehringer
Mannheim, Cat. No. 1544 675), quantifying histone-asso-
ciated DNA fragments in the cytoplasmic fraction of cell
lysates by spectrophotometry (405 nm). The presence of
mono- and oligonucleosomes has been considered as a
feature of cells undergoing apoptosis (Bonfocco et al.
1995). However, it cannot be excluded that it also repre-
sents a caspase-3 independent cell death. Indeed, using
cleaved caspase-3, as a marker for caspase-dependent
apoptosis, and 150 kDa calpain-dependent cleavage of
a-fodrin, as a marker for necrosis, Ginet et al. (2009)
showed an increase of the 150-kDa a-fodrin product in
neocortex of rat, 30 min to 24 h after a hypoxic–ischaemic
insult at P7, while, in the same preparation, activation of
caspase-3 levels started to increase weakly at 6 h, reaching
a maximum at 24 h. Figure 6 shows that cell death could
be monitored in the frontal cortex of pups 10 min after
delivery, which was signiﬁcantly increased after 10 min of
asphyxia, reaching a maximum after 21 min of asphyxia. A
parallel but less pronounced effect was observed 40 min
after delivery.
Interestingly, no sign of apoptosis could be observed
with haematoxylin–eosin histochemistry up to P8. At P8,
nuclear fragmentation could be quantiﬁed, and correlated
with the length of the insult (Dell’Anna et al. 1997; Lubec
et al. 1997a). A signiﬁcant increase of nuclear fragmenta-
tion was already observed after mild insults, when the rate
of survival was still 100%. This is a very important
observation because it shows delayed cell death occurring
when clinical parameters indicate a rather benign condi-
tion, an issue recently discussed by Odd et al. (2009).
Organotypic cultures
The model of perinatal asphyxia allows short- and long-
term observations in the same experimental series. It also
allows performance of in vitro studies for investigating
particular issues elicited by the insult. Thus, caesarean-
delivered control and asphyxia-exposed animals can be
used for preparing organotypic cultures to study neurocir-
cuitry development in vitro. The organotypic culture model
moves the pattern of innervation to an earlier stage, forcing
neurites to seek the corresponding tissue and cell targets,
until innervation plexuses are established (Plenz et al.
1998; Gomez-Urquijo et al. 1999, Morales et al. 2003;
Klawitter et al. 2007). Thus, the model makes it possible to
speciﬁcally investigate the effect of perinatal asphyxia on
postnatal neuritogenesis. In organotypic cultures from
asphyxia-exposed rats, we found a decrease in the number
of secondary to higher level branching of tyrosine
hydroxylase (TH)-positive neurites (Morales et al. 2003;
Klawitter et al. 2005), illustrating the vulnerability of the
dopaminergic systems to perinatal asphyxia (Fig. 7).
A regional vulnerability to the long-term effects elicited
by perinatal asphyxia has been reported by several labo-
ratories, affecting dopaminergic (Klawitter et al. 2007) and
nNOS neuronal systems (Ezquer et al. 2006; Jiang et al.
1997; Capani et al. 1997; Loidl et al. 1997). With the or-
ganotypic culture model, we demonstrated that the number
and neurite trees of nNOS positive neurons in neostriatum
are decreased by perinatal asphyxia, while in the substantia
nigra there is a paradoxical increase in the number of
nNOS positive neurons (Klawitter et al. 2006, 2007), fur-
ther underpinning region speciﬁc differences observed in
the interactions established between dopamine and nNOS
neurons in mesencephalon and telencephalon (Gomez-Ur-
quijo et al. 1999; Herrera-Marschitz et al. 2000).
Apoptosis and neurogenesis after perinatal asphyxia
The neurocircuitries of the hippocampus are also vulnera-
ble to hypoxic/ischaemic insults. Using nuclear Hoechst
staining and DNA fragmentation assayed by a TUNEL
detection kit (NeuroTACS, R&D systems, Minneapolis,
MN, USA), we demonstrated that perinatal asphyxia
Fig. 6 Early and delayed cell death in neocortex of asphyxia-exposed
and control rat neonates. Early cell death was measured with an
ELISA kit quantifying histone-associated DNA fragments in a
cytosolic fraction (arbitrary units) 10 (ﬁlled circles) and 40 (ﬁlled
squares) min after delivery (Lubec et al. 1997a). Nuclear fragmen-
tation (number of fragmented nuclei), as an indication of delayed cell
death was assayed with haematoxylin–eosin histochemistry, 1–8 days
after delivery (ﬁlled triangles) (Dell’Anna et al. 1997). Abscissa time
(min) of immersion into a water bath at 37C (asphyxia); ordinate
survival in percentage (%). Compared to zero asphyxia
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123increases apoptosis in the hippocampus (Morales et al.
2008), as previously suggested (Dell’Anna et al. 1997). An
increase of apoptotic nuclei was observed in CA1, CA3
region and supra- and infrapyramidal bands of the hippo-
campus at P7, and even at P30. That effect was accom-
panied by an increase in the levels of the pro-apoptotic
protein BAD measured by western blots of hippocampal
extracts from asphyxia-exposed and control animals.
Interestingly, the levels of the anti-apoptotic protein BCL-2
and bFGF were concomitantly increased, suggesting a
functional recovery promoted via the MAPK/ERK pathway
(Morales et al. 2008). Indeed, we have recently found that
phosphorylated ERK-1, and FLRT-3 levels are increased
following perinatal asphyxia, as well as the levels of the
inhibitory modulator Spry (Tsang and Dawid 2004; Cabrita
et al. 2006), suggesting that these proteins also play a role
during postnatal stages (Ca ´rdenas et al. 2009).
We have found that the increase of apoptotic like nuclei
is particularly remarkable in CA3, in contrast to the
observation that more apoptotic cells are seen in CA1 than
in CA3 region following hypoxia/ischaemia at P7 (Nakaj-
ima et al. 2000; Kawamura et al. 2005). It has been recently
reported that the main type of cell death seen in CA3 is by
autophagy, but not in CA1, where apoptosis predominates
following hypoxia/ischaemia at P7 (Ginet et al. 2009).
Using immunocytochemistry against LC3, a protein
involved in autophagosome formation, the authors reported
an increase of the number of LC3 positive dots in CA3,
already 6 h after the hypoxic/ischaemic insult in the
cytosol of cells positive for the neuronal marker NeuN.
However, the number of punctate LC3-positive neurons
decreased at 48 and 72 h (Ginet et al. 2009).
Postnatal neurogenesis has been investigated in the hip-
pocampus of asphyxia-exposed rats, labelled with the thy-
midine analogue 5-bromo-20-deoxyuridine (BrdU). A
signiﬁcant increase of mitotic activity has been observed,
both in brain tissue and organotypic cultures from asphyxia-
exposed animals, mainly localized in the DG (Morales et al.
2005, 2007). Only 25% of the new cells co-expressed MAP-
2, suggesting proliferation of other types of cells, including
astrocytes, microglia, as well as ﬁbroblasts.
In recent studies on neurogenesis with organotypic cul-
tures from the SVZ, we have observed an increase of BrdU/
MAP-2 positive cells in cultures from asphyxia-exposed
animals (Espina-Marchant et al. 2009). The studies on neu-
rogenesis occurring in the SVZ are interesting, because they
could reveal mechanisms for neuronal repair of the adjacent
neostriatum. We are also exploring the idea that neurogen-
esis in the DG of the hippocampus and SVZ is modulated by
dopamine terminals from the mesencephalon, which is an
attractive hypothesis that provides an explanation for the
paradoxical effect of methylphenidate (Ritalin
), used for
children suffering from attention deﬁcit syndrome (ADS).
Dopamine is perhaps needed for inducing neurogenesis in
DGandSVZ,promotingneuronalplasticity,assuggestedfor
Ritalin treated children (see Grund et al. 2006; Schaeferd
et al. 2009; Kim et al. 2009; also see Banerjee et al. 2009;
Ruocco et al. 2010). The idea is to further investigate the
receptors involved in this mechanism, to suggest the use of
selective dopamine agonists to treat ADS like syndromes.
Behavioural and cognitive deﬁcits
Motor and cognitive alterations of variable severity,
including cerebral palsy, seizures, spasticity, ADS, hyper-
activity, mental retardation and/or neuropsychiatric
Fig. 7 Neurite atrophy induced by perinatal asphyxia. Tyrosine
hydroxylase (TH)-positive neurons in triple organotypic cultures at
21 days in vitro (DIV) from control (a) and asphyxia-exposed
(20 min, at 37C) (b) pups. The TH immunostaining (BCIP/NBT)
was counterstained with fast red for labelling nuclei. The white
arrows in a and b indicate the neurons drawn through camera lucida
in c and d, respectively. Bars 20 lm (from Morales et al. 2003; with
permission)
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123syndromes with delayed clinical onset have been associ-
ated with perinatal asphyxia (du Plessis and Volpe 2002;
Van Erp et al. 2002; Kaufman et al. 2003; Vannuci and
Hagberg 2004; de Hann et al. 2006; Odd et al. 2009). In the
rat, several studies have investigated the behavioural
effects associated with perinatal asphyxia, addressing
motor function (Bjelke et al. 1991; Chen et al. 1995),
emotional behaviour (Dell’Anna et al. 1991, Hoeger et al.
2000; Venerosi et al. 2004, 2006, Simola et al. 2008;
Morales et al. 2010), and spatial memory (Boksa et al.
1995; Iuvone et al. 1996; Hoeger et al. 2000, 2006; Loidl
et al. 2000; Van de Berg et al. 2003; Venerosi et al. 2004).
We have investigated whether perinatal asphyxia may
producelong-termeffectsoncognitiveperformance,usinga
behavioural test applied under ethological-like conditions,
devoid of any stressful cues or primary reinforcers, such as
swimming, food deprivation or electric shocks (Ennaceur
and Delacour 1988). The test consists of discriminating
between objects differing in shape and colour, without any
genuine signiﬁcance to the rat, or being previously associ-
ated with any rewarding or aversive stimuli. During the ﬁrst
session,twocopiesofthesameobjectarepresentedtotherat
for 4 min, and then again, during the second session, when
oneofthepreviouslypresentedobjectsisreplacedbyanovel
one, similar in size, but different in shape and/or colour. The
ideaisthattherathastorecognizethenovelobject,spending
longer time exploring the novel than that previously pre-
sented. The ﬁrst and the second sessions can be separated by
different time intervals, for evaluating the consolidation of
learning. A good memory would be able to recognize a
previously presented object after a long time elapsing
between a ﬁrst and second session, meaning that the animal
would concentrate on exploring the novel object. In our
studies, we used a 15 or 60 min interval, and the animals
were studied at 3 months of age (Simola et al. 2008). As
shown in Fig. 8, no differences were observed between
asphyxia-exposed (20 min asphyxia) and control animals
when a 15-min interval elapsed between the ﬁrst and the
second session. Both asphyxia-exposed and control rats
recognized the novel stimulus similarly well, spending
longer time exploring the novel object. However, when
60 min elapsed between the ﬁrst and second session,
asphyxia-exposed animals spent less time exploring the
novelobject,indicatingthatasphyxia-exposedratscouldnot
recognize its novelty. Conversely, asphyxia-exposed rats
could not remember that the object was already presented
during the ﬁrst session. This is a straightforward experiment
showing a subtle consequence of a metabolic insult (anoxia)
occurring at birth, impairing a cognitive function that will
show up only after a proper challenge. It is very much rem-
iniscent to the clinical experience revealing effects only
when the child starts primary school (see Odd et al. 2009;
Strackx et al. 2010).
Therapeutic strategies
Hypothermia
In the clinical scenario, after resuscitation of an infant with
birth asphyxia, the emphasis is on supportive therapy,
although only few ideas exist for preventing, or even
reversing the neurotoxic cascade elicited by hypoxia (see
Volpe 2001; du Plessis and Volpe 2002). Hypothermia has
been pointed out to be an effective intervention to attenuate
the secondary neuronal injury elicited by hypoxia (see
Engidawork et al. 2001). Although there is still concern for
a narrow therapeutic window (Engidawork et al. 2001) and
for a lack of a clear mechanism of action for the effect of
hypothermia (Herrera-Marschitz et al. 1993, 1994; see
Gluckman et al. 2005; Hoeger et al. 2006; Groenendaal and
Brouwer 2009; Edwards 2009), there are already several
multicentre trial initiatives on this strategy (Gunn and
Thoressen 2006). There are several recent excellent
reviews about the new strategies for cooling the brain of
human babies who suffer asphyxia during birth (Shankaran
Shankaran 2009; Groenendaal and Brouwer 2009),
including a very insightful review discussing the effect of
hypothermia on pharmacokinetic and pharmacodynamic
parameters of drug regimes used in neonatology (van den
Broek et al. 2010).
Nicotinamide
Nicotinamidehasbeenproposedtoprotectagainstoxidative
stress (Yan et al. 1999; Wan et al. 1999), ischaemic injury
(Sakakibara et al. 2000; Yang et al. 2002) and inﬂammation
(Ducrocq et al. 2000) in neonatal rat brain by replacing
Fig. 8 Effect of perinatal asphyxia on object recognition assessed
3 months after delivery. Asphyxia-exposed (20 min, at 37C) and
control rats recognized similarly well a previously experienced object
whenever a 15 min period elapsed between a ﬁrst-learning and a
second-test session. However, asphyxia-exposed animals failed to
recognize a previously experienced object whether the period
between the ﬁrst and second session was extended to 60 min.
* P\0.05 (n = 13–18) (from Simola et al. 2008, with permission)
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? (Zhang et al. 1995). We have reported
(Bustamante et al. 2003) that nicotinamide prevents several
ofthe changesinduced byperinatalasphyxiaon monoamine
contents, even if the treatment was delayed for 24 h, sug-
gesting a clinically relevant therapeutic window. We have
later conﬁrmed that observation, reporting that neonatal
treatmentwithnicotinamidepreventsthelong-termeffectof
perinatal asphyxia on dopamine release monitored with in
vivo microdialysis three months after birth (Bustamante
et al. 2007). These ﬁndings support the idea that nicotin-
amide can constitute a therapeutic strategy against the long-
term deleterious consequences of perinatal asphyxia, as
already proposed for several other pathophysiological con-
ditions (see Virag and Szabo 2002). Nevertheless, the
mechanisms explaining the protection provided by nicotin-
amide have to be further investigated, including histone
deacetylation, a mechanism proposed for the recent intro-
duction of nicotinamide as a treatment for Alzheimer’s dis-
ease and other taupathies (Green et al. 2008).
Ultrapotent novel PARP-1 inhibitors
The PARP-1 inhibitory action of nicotinamide is well
established (see Virag and Szabo 2002). We have observed
that therapeutic doses of nicotinamide (0.8 mmol/kg, i.p.)
produced a long-lasting inhibition of PARP-1 activity
measured in brain and heart from asphyxia-exposed and
control animals (Allende et al. 2009). As shown in Fig. 9,a
signiﬁcant inhibition of PARP-1 activity in heart and brain
was observed 1 and 8 h after a single dose of nicotinamide.
The use of nicotinamide has been challenged because of its
low potency, limited cell uptake and short cell viability, stim-
ulating the search for more speciﬁc compounds, such as
3-aminobenzamide (Ducrocq et al. 2000; Hortobagyi et al.
2003; Koh et al. 2004); 3,4-dihydro-5-[4-(1-piperidinyl)but-
oxy]-1(2H)-isoquinolinone (DPQ) (Takahashi et al. 1999);
PJ34 (Abdelkarim et al. 2001); N-3-(4-Oxo-3,4-dihydroph-
thalazin-1-yl)phenyl-4-(morpholin-4-yl) butanamide methane
sulphonate monohydrate (ONO-1924H) (Kamanaka et al.
2004); 5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)
propyl]-4(3H)-quinazoline (FR247304) (Iwashita et al. 2004);
and 2-methyl-3,5,7,8-tetrahydrothiopyranol[4,3-d]pyrimidine-
4-one] (DR2313) (Nakajima et al. 2005). Ultrapotent novel
PARP inhibitors are now entering human clinical trials for
reducing parenchymal cell necrosis following stroke and/or
myocardial infarction, down-regulating multiple pathways of
inﬂammation and tissue injury following circulatory shock,
colitis or diabetic complications (Jagtap and Szabo 2005).
Fig. 9 Effect of nicotinamide on PARP-1 activity in brain and heart
from asphyxia-exposed and control rat neonates. PARP-1 activity was
measured by a PARP Universal Colorimetric Assay (R&D Systems,
Minneapolis, MN; catalogue #4677-096-K) in heart (a, b) and brain
(c, d) and tissue dissected from asphyxia-exposed (AS, n = 5; AN,
n = 5) and control (CS, n = 5; CN, n = 5) animals, treated with
saline (1 ml/kg, i.p.) (AS, CS), or nicotinamide (0.8 mmol/kg, i.p.)
(CN, AN) 1 h after delivery. The animals were dissected 1 h or 8 h
after a single administration of saline or nicotinamide. Open and grey
columns PARP-1 activity in CS and AS pups, respectively. Dashed
columns PARP-1 activity in CN and AN pups, respectively.
* P\0.05 (Allende et al. in preparation)
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versus old molecules
There is, however, concern about applying ultrapotent
PARP-1 inhibitors during development, since it has been
shown that PARP-1 is required for efﬁcient repair of dam-
aged DNA (Trucco et al. 1998; Schultz et al. 2003). There-
fore, it has been suggested that moderate PARP-1 inhibitors
should bechosenforneuronal protection,wheneverused for
paediatricpatients (Moonenetal.2005;Geraetsetal.2006).
Severalnaturallyoccurringcompoundshavebeensuggested
toinhibitPARP-1over-activation. Caffeine metabolites,but
notcaffeine(1,3,7-trimethylxanthine)itself,areinhibitorsof
PARP-1 at physiological concentrations (Geraets et al.
2006).Theophylline(1,3-dimethylxanthine)isaninteresting
candidatetobeinvestigated,becauseitalreadyhasaclinical
application for chronic obstructive pulmonary diseases in
children (Moonen et al. 2005). The most attractive com-
pound is, however, paraxanthine (1,7-dimethylxanthine)
(Geraets et al. 2006), the major metabolite of caffeine in
humans, whose clinical potential we already proposed at the
beginning of the 1990s (Ferre et al. 1991).
Nicotinamide is still an interesting molecule because of
its low potency, which can be an advantage when used for
developing animals, antagonizing the effects elicited by
PARP-1 overactivation without impairing DNA repair or
cell proliferation. Nicotinamide has been proposed as an
agent against oxidative stress (Yan et al. 1999; Wan et al.
1999), and its pharmacodynamic properties can provide
advantages over more selective compounds. Furthermore,
nicotinamide has already been tested in human clinical
trials without showing any signiﬁcant toxicity, although its
therapeutic efﬁcacy is still controversial (Macleod et al.
2004). Nicotinamide can constitute a lead for exploring
compounds with similar or better pharmacological proﬁles.
We are particularly interested in testing the substituted
benzamide N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-
5-sulphamoyl benzamide (Sulpiden
, and other benzam-
ides of clinical use in paediatrics); and the xanthine
analogs, 1,3-dimethylxanthine and 1,7-dimethylxanthine,
substances already used for different clinical applications.
PARP-1 is still a relatively novel therapeutic target.
Putative PARP-1-inhibitory substances should be system-
atically characterized, evaluating their potential as drugs
for paediatric use.
Genomics, transcriptomics, proteomics, epigenetics
and beyond: levels for molecular network interactions
The above described pivotal role of the PARP family of
transcription factors in perinatal hypoxic conditions with
long-lasting consequences on brain development and
tentative deﬁcits of decisive brain functions brings up the
question of the molecular mechanisms affected by the
speciﬁc environmental impact via gene transcription. Very
likely, a host of molecular interactions is disturbed by such
a profound impact at a critical time period of life (Bertrand
et al. 2007).
Gene transcription may be affected by modiﬁcations of
methylation patterns of various gene promoters or changes
of histone methylations/acetylations or additional modiﬁ-
cations. These events are particularly vulnerable to envi-
ronmental inﬂuences. Moreover, they can be long-lasting
and even be inherited.
At this level, it is intriguing, as well, to turn the view to
transcription factors, because they are at the core of regula-
tion of whole molecular networks; of their compositions, as
well as activities. Not only PARPs, but also hypoxia induc-
ible factor 1 (HIF-1), AIF (see Acker and Acker 2004), and
other factors known to be affected by hypoxic conditions,
regulate the transcription of speciﬁc arrays of genes with
respective responsive elements in their promoters (Fig. 10).
For clarity purpose, Fig. 10 only shows effects of a few
transcription factors on two or three genes (instead of
dozens). Each gene can give rise to several gene products
(proteins) by alternative splicing, multiple start codons, etc.
The gene products then interact with each other in well-
balanced molecular networks (Ooi and Wood 2008). Evi-
dently, disturbances of expression or function of only one
transcription factor affects the expression of many genes
and of their gene products, and have unpredictable conse-
quences on the dynamics of the molecular networks. Such
disturbances can be compared with wave-like bursts orig-
inating from multiple sources and interfering with the
above-balanced molecular activity oscillations. Eventually,
the outcome depends on the ‘buffering’ capacity of those
oscillatory networks. The observations following hypoxic
conditions, as outlined above, rather speak to insufﬁcient
buffering capacity, which results in stronger or weaker
overshoot reactions. Consequences may be acute and dra-
matic, with cell death and tissue damage, or milder, but
with long-lasting and subtle deﬁcits of brain function.
It is a huge challenge in molecular biology to under-
stand control and regulation of gene expression including
all the feedback mechanisms between proteins and genes,
and between genes and the environment. We need to
obtain more thorough insights into these intricate and very
dynamic events occurring on these different levels. The
task is to understand Fig. 10, completed by dozens of
transcription factors with hundreds or thousands of genes
controlled by combinations of those factors, and completed
on the protein network level by many more proteins that
keep interacting in self-sustained, but also exogenously
inﬂuenced actions. The task of understanding such a
complex molecular system is bewildering. However, there
618 Neurotox Res (2011) 19:603–627
123is hope that computers equipped with smart programs can
help to unravel and visualize those sophisticated molecular
systems. Much is known about the biochemistry of pro-
teins, metabolic interactions or signalling pathways. Many
of those data could be inserted into mathematical algo-
rithms, using graph-theoretical approaches (Abul-Husn
et al. 2009; Lipshtat et al. 2009), Petri nets (Wu and Voit
2009) or ordinary and non-linear differential equations (Ho
et al. 2007). Differential equations are probably the most
comprehensible way to characterize and deal with the
dynamic behaviour of molecular networks. Because,
however, for each node (molecule) of the network, one
equation has to be constructed, their application becomes
unfeasible with the number of nodes to be described. The
present computational power reaches its limits when
thousand or more of those equations have to be solved.
An option that has been used frequently on biological
networks, such as on metabolic, protein and gene networks,
are scale-free topologies (Mattha ¨us et al. 2010). They can
be distinguished into four classes of graphs which are very
useful for biological applications: (i) regular; (ii) random;
(iii) ‘small-world’, and (iv) scale-free graphs. It is one of
the major ﬁndings of the last decade of intense studies of
biological networks, that scale-free graphs are able to
represent the topology of such networks more accurately
than other types of random graphs (McGarry et al. 2007).
The strength of graph theory is that it can represent a
complex system in a uniﬁed formal language of nodes and
links. Strictly speaking, a graph representation of metabo-
lism consists of two types of nodes, metabolites and
enzymes, where either the metabolites or the enzymes are
the nodes. This system is described by ﬂux-balance-anal-
ysis (FBA), which is a widely accepted method for in silico
studies of metabolic states (Oberhardt et al. 2009; Feala
et al. 2009). Its severe limitation, it only describes steady
states, has been reﬁned by the incorporation of temporal
and gene regulatory information.
In terms of enzymes, the internal dynamics of any of
these molecules is important. Since typically these
dynamics are complex and their details are not well enough
known, their operation may be modelled like an automaton.
In principle, cellular automata on graphs allow assessing
dynamic changes due to variation of graph topology (Kier
et al. 2005). Cellular automata on graphs serve to investi-
gate dynamic information storage, as reported for memory
storage in brain astrocytes (Caudle 2006), or used as
models of pattern formation. Molecular patterns are
believed to be characteristic for a disease. These patterns,
however, are not static. Graph-theoretical approaches
appear to be very useful to animate those patterns and in
this way show their changes over time. We think that those
kinds of animations are extremely important to obtain
major understandings about causes, progression and con-
sequences of chronic diseases.
Relevance and conclusions
The present review addresses an important health problem,
with both paediatric and neuropsychiatric implications. A
long-term goal is to design new therapeutic strategies for
preventing or even treating the effects of perinatal
asphyxia, as well as to understand the mechanisms by
which early metabolic insults prime the development of the
CNS.
Fig. 10 Transcription factor-dependent molecular networks. Three
molecular levels are displayed in the ﬁgure. Transcription factors
control transcription of sets of genes speciﬁc for each factor at the
DNA level (DNA and histone modiﬁcations, which are also involved
in regulation of gene transcription are omitted). This concerted action
is ﬁne-tuned on the transcript level by various mRNA processing
events (alternative splicing, editing, etc., not shown). Then the
transcripts (here 1–10) are translated into proteins (1–10; within
circles) that fulﬁl their tasks within large molecular networks by
interaction with speciﬁc partner molecules. Because of the inﬂuence
of one transcription factor on the expression of several proteins, only
subtle disturbances on the DNA level may have substantial effects on
the complex molecular networks on the protein level. Often, the
complete set of genes controlled by a given transcription factor is not
known. Therefore, the array in the protein network (as shown here, for
example, 3 genes for PARP1 and AIF, and 2 genes for HIF and p300)
belonging to these factors is incomplete. Furthermore, even though
there would be a complete picture of some transcription factors on the
protein level, activities of proteins with signiﬁcant functions, i.e. not
belonging to the genes regulated by the given transcription factors,
may be compromised by the altered concentrations (activities) of the
proteins belonging to the given transcription factor regulated genes.
An assessment of these complex interactions is not possible by human
intuition, but is feasible by computer simulations based on intelligent
software programs. Mathematical simulations of the behaviour of
those protein networks can help to identify nodes critical for overall
network functioning, and may even predict consequences of network
disturbances (see Mattha ¨us et al. 2010). PARP-1, poly (ADP-ribose)
polymerase-1; HIF-1, hypoxia inducible factor; AIF, apoptosis-
inducing factor; p300, Cbp/p300-interacting transactivator
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cation of critical molecular, morphological, physiological
and pharmacological parameters, specifying variables that
should be considered when planning neonatal care and
development programmes.
The pivotal role of the PARP family of transcription
factors in perinatal hypoxic conditions with long-lasting
consequences on brain development and deﬁcits of
decisive brain functions, brings up the question of the
molecular mechanisms affected by speciﬁc environmental
impact via gene transcription. A host of molecular
interactions is likely disturbed by such a profound impact
at a critical time period of life. Gene transcription may be
affected by modiﬁcations of methylation patterns of
various gene promoters or changes of histone methyla-
tions/acetylations or additional modiﬁcations. These
events are particularly vulnerable to environmen-
tal inﬂuences; they can be long-lasting and even be
inherited.
It is a huge challenge in molecular biology to understand
control and regulation of gene expression including all the
feedback mechanisms between proteins and genes, and
between genes and the environment. We need to obtain
more thorough insights into these intricate and dynamic
events occurring on these different levels. While nobody
will be able to overlook such a kind of complex molecular
system, there is hope that computers equipped with smart
programs will help to unravel and visualize those sophis-
ticated molecular systems. Mathematicians in bioinfor-
matics, biophysics and related disciplines are working on
solutions to identify molecular network and neuronal wir-
ing patterns characteristic for speciﬁc brain disorders and
to develop tools to simulate dynamic actions of molecules
and cells. With these approaches, we hope to learn more
about the past development of a disease and to make pre-
dictions of its further progression. Ideally, these efforts
should give valuable hints of pivotal molecules, cells or
neurocircuitries to be addressed by pharmacological
measures.
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